NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 287 filers reported holding NOVOCURE LTD in Q3 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $592,115 | -45.9% | 36,215 | +38.1% | 0.00% | 0.0% |
Q2 2023 | $1,093,654 | -31.5% | 26,233 | -1.1% | 0.00% | -50.0% |
Q1 2023 | $1,595,815 | +410.0% | 26,535 | +506.0% | 0.00% | – |
Q4 2022 | $312,920 | -78.1% | 4,379 | -76.2% | 0.00% | -100.0% |
Q3 2022 | $1,432,000 | +30.4% | 18,392 | +18.1% | 0.00% | 0.0% |
Q2 2022 | $1,098,000 | -18.2% | 15,567 | +157.5% | 0.00% | +100.0% |
Q2 2021 | $1,342,000 | +287.9% | 6,046 | +132.3% | 0.00% | – |
Q1 2021 | $346,000 | -46.9% | 2,603 | -30.8% | 0.00% | -100.0% |
Q4 2020 | $651,000 | +110.7% | 3,763 | +36.9% | 0.00% | – |
Q3 2020 | $309,000 | -35.2% | 2,748 | -63.6% | 0.00% | -100.0% |
Q2 2019 | $477,000 | +97.9% | 7,551 | +51.0% | 0.00% | – |
Q1 2019 | $241,000 | – | 5,002 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 350,884 | $77,833,000 | 15.51% |
HARTLINE INVESTMENT CORP/ | 302,194 | $67,033,000 | 8.47% |
Darsana Capital Partners LP | 700,000 | $155,274,000 | 4.42% |
MORGAN JESS S & CO INC | 23,775 | $5,274,000 | 3.47% |
Soleus Capital Management, L.P. | 98,975 | $21,955,000 | 3.38% |
Montanaro Asset Management Ltd | 116,650 | $25,875,000 | 3.26% |
Taylor Frigon Capital Management LLC | 31,035 | $6,884,000 | 2.15% |
Rhenman & Partners Asset Management AB | 120,000 | $26,618,000 | 1.81% |
COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $2,218,000 | 1.33% |
Derbend Asset Management | 5,789 | $1,284,000 | 1.20% |